
PIXELGEN PROXIOME KIT
ANALYZE THE MOLECULAR BASIS OF CELL FUNCTION THROUGH PROTEIN INTERACTOMICS
The Pixelgen Proxiome Kit, Immuno 155, based on the Proximity Network Assay, delivers cell surface protein interactomics in an unprecedented way. The validated protein panel consists of 155 immune cell surface protein targets and the output is a detailed map of up to 50,000 data points per single cell representing protein clustering, colocalization, and abundance.
News

About Pixelgen Technologies
Pixelgen Technologies AB is on a mission to deliver biology at the highest resolution by understanding the molecular basis of cellular function with new tools and technologies that decipher the protein interactomics of single cells in unprecedented ways. The company’s patented Proximity Network Assay delivers nanoscale spatial analysis of immune cell proteins at ultra-high capacity and underpins the Pixelgen Proxiome Kit for precision medicine. A foundational technology, the Proximity Network Assay will power a portfolio of products for translational research to accelerate advances in immunology, hematology, and cell therapy. Pixelgen was founded in 2020 by a team of passionate, experienced innovators and entrepreneurs and is venture-backed.
